JENNIFER A BERRY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SAINT LOUIS, MO NPI 1366719072
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MO Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$9,339.22
- Category: General Payments
- Program years: PY2021–2024
- Record count: 536
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,891.43 across 102 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,891.43 | 102 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $362.50 | 17 |
| ABBVIE INC. | $212.25 | 21 |
| Novo Nordisk AS | $139.16 | 8 |
| ViiV Healthcare Company | $133.37 | 10 |
| Merck Sharp & Dohme Corporation | $122.55 | 4 |
| Lilly USA, LLC | $107.83 | 3 |
| Acerta Pharma LLC | $94.72 | 5 |
| PFIZER INC. | $82.63 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $63.88 | 3 |
| ITI, Inc. | $49.13 | 2 |
| Medtronic, Inc. | $47.04 | 2 |
| Antares Pharma, Inc. | $45.76 | 2 |
| EMD Serono, Inc. | $43.44 | 2 |
| Tris Pharma Inc | $42.38 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $41.28 | 3 |
| Napo Pharmaceuticals Inc | $40.75 | 2 |
| Amgen Inc. | $36.23 | 2 |
| Theratechnologies Inc. | $29.70 | 1 |
| ABIOMED | $25.27 | 1 |
| Lundbeck LLC | $25.22 | 1 |
| Abbott Laboratories | $24.29 | 1 |
| DEXCOM, INC. | $23.84 | 1 |
| Inspire Medical Systems, Inc. | $23.66 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.63 | 1 |
| Acella Pharmaceuticals, LLC | $21.57 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $17.13 | 1 |
| E.R. Squibb & Sons, L.L.C. | $14.22 | 1 |
By program year
Records — PY2024 (102)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.